VALEANT PHARMACEUTICALS INTL's ticker is and the CUSIP is 91911K902. A total of 13 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $145,000 | – | 20,000 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 360,000 | $8,838,000 | 2.84% |
GLENHILL ADVISORS LLC | 38,075 | $9,872,000 | 0.59% |
FARLEY CAPITAL L.P. | 17,000 | $417,000 | 0.55% |
GROUP ONE TRADING, L.P. | 1,699,000 | $41,710,000 | 0.45% |
Birch Grove Capital LP | 20,000 | $145,000 | 0.14% |
CMT Asset Management Ltd | 50,300 | $1,235,000 | 0.06% |
Pentwater Capital Management LP | 220,000 | $5,401,000 | 0.05% |
SIMPLEX TRADING, LLC | 8,586 | $625,000 | 0.04% |
Timber Hill LLC | 122,200 | $3,000,000 | 0.01% |
JPMORGAN CHASE & CO | 580,000 | $14,239,000 | 0.00% |